Papers: 10.3389/fmolb.2021.690615

https://doi.org/10.3389/fmolb.2021.690615

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”

Cited by: 1
Author(s): Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Andrea Malfettone, José Manuel Pérez-García, Antonio Llombart‐Cussac, Javier Cortés, Almudena Pardo, Jordi Pérez‐López
Published: over 5 years ago

Software Mentions 1